vs
迈梭电子（MEI）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
迈梭电子的季度营收约是Orthofix Medical Inc.的1.1倍（$246.9M vs $219.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -4.0%，领先3.0%），Orthofix Medical Inc.同比增速更快（2.0% vs -15.6%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-11.6M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -2.5%）
迈梭电子是一家总部位于美国伊利诺伊州芝加哥的跨国企业，主要业务涵盖工程研发、生产制造与销售服务，目前在全球14个国家设有超过35个运营网点，全球员工总数约6500人。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
MEI vs OFIX — 直观对比
营收规模更大
MEI
是对方的1.1倍
$219.9M
营收增速更快
OFIX
高出17.6%
-15.6%
净利率更高
OFIX
高出3.0%
-4.0%
自由现金流更多
OFIX
多$28.4M
$-11.6M
两年增速更快
OFIX
近两年复合增速
-2.5%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $246.9M | $219.9M |
| 净利润 | $-9.9M | $-2.2M |
| 毛利率 | 19.3% | 71.1% |
| 营业利润率 | 1.2% | 0.2% |
| 净利率 | -4.0% | -1.0% |
| 营收同比 | -15.6% | 2.0% |
| 净利润同比 | -518.8% | 92.4% |
| 每股收益（稀释后） | $-0.28 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MEIOFIX
| Q4 25 | $246.9M | $219.9M | ||
| Q3 25 | $240.5M | $205.6M | ||
| Q2 25 | $257.1M | $203.1M | ||
| Q1 25 | $239.9M | $193.6M | ||
| Q4 24 | $292.6M | $215.7M | ||
| Q3 24 | $258.5M | $196.6M | ||
| Q2 24 | $277.3M | $198.6M | ||
| Q1 24 | $259.5M | $188.6M |
净利润MEIOFIX
| Q4 25 | $-9.9M | $-2.2M | ||
| Q3 25 | $-10.3M | $-22.8M | ||
| Q2 25 | $-28.3M | $-14.1M | ||
| Q1 25 | $-14.4M | $-53.1M | ||
| Q4 24 | $-1.6M | $-29.1M | ||
| Q3 24 | $-18.3M | $-27.4M | ||
| Q2 24 | $-57.3M | $-33.4M | ||
| Q1 24 | $-11.6M | $-36.0M |
毛利率MEIOFIX
| Q4 25 | 19.3% | 71.1% | ||
| Q3 25 | 18.1% | 72.2% | ||
| Q2 25 | 7.6% | 68.7% | ||
| Q1 25 | 17.2% | 62.8% | ||
| Q4 24 | 19.8% | 69.0% | ||
| Q3 24 | 17.3% | 68.7% | ||
| Q2 24 | 12.8% | 67.8% | ||
| Q1 24 | 14.3% | 67.5% |
营业利润率MEIOFIX
| Q4 25 | 1.2% | 0.2% | ||
| Q3 25 | 0.5% | -8.3% | ||
| Q2 25 | -9.2% | -7.9% | ||
| Q1 25 | -0.9% | -25.2% | ||
| Q4 24 | 3.2% | -5.3% | ||
| Q3 24 | -2.9% | -9.6% | ||
| Q2 24 | -22.2% | -12.5% | ||
| Q1 24 | -1.2% | -15.6% |
净利率MEIOFIX
| Q4 25 | -4.0% | -1.0% | ||
| Q3 25 | -4.3% | -11.1% | ||
| Q2 25 | -11.0% | -6.9% | ||
| Q1 25 | -6.0% | -27.4% | ||
| Q4 24 | -0.5% | -13.5% | ||
| Q3 24 | -7.1% | -13.9% | ||
| Q2 24 | -20.7% | -16.8% | ||
| Q1 24 | -4.5% | -19.1% |
每股收益（稀释后）MEIOFIX
| Q4 25 | $-0.28 | $-0.05 | ||
| Q3 25 | $-0.29 | $-0.57 | ||
| Q2 25 | $-0.79 | $-0.36 | ||
| Q1 25 | $-0.41 | $-1.35 | ||
| Q4 24 | $-0.05 | $-0.76 | ||
| Q3 24 | $-0.52 | $-0.71 | ||
| Q2 24 | $-1.62 | $-0.88 | ||
| Q1 24 | $-0.33 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $118.5M | $82.0M |
| 总债务越低越好 | $332.5M | — |
| 股东权益账面价值 | $679.3M | $450.0M |
| 总资产 | $1.3B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.49× | — |
8季度趋势，按日历期对齐
现金及短期投资MEIOFIX
| Q4 25 | $118.5M | $82.0M | ||
| Q3 25 | $121.1M | $62.9M | ||
| Q2 25 | $103.6M | $65.6M | ||
| Q1 25 | $103.8M | $58.0M | ||
| Q4 24 | $97.0M | $83.2M | ||
| Q3 24 | $111.3M | $30.1M | ||
| Q2 24 | $161.5M | $26.4M | ||
| Q1 24 | $122.9M | $27.0M |
总债务MEIOFIX
| Q4 25 | $332.5M | — | ||
| Q3 25 | $323.4M | $157.2M | ||
| Q2 25 | $317.6M | $157.0M | ||
| Q1 25 | $327.9M | $156.9M | ||
| Q4 24 | $340.6M | $157.0M | ||
| Q3 24 | $296.0M | $118.5M | ||
| Q2 24 | $330.9M | $118.0M | ||
| Q1 24 | $331.3M | $118.2M |
股东权益MEIOFIX
| Q4 25 | $679.3M | $450.0M | ||
| Q3 25 | $688.1M | $442.5M | ||
| Q2 25 | $693.3M | $458.3M | ||
| Q1 25 | $704.3M | $458.3M | ||
| Q4 24 | $738.3M | $503.1M | ||
| Q3 24 | $744.4M | $525.9M | ||
| Q2 24 | $766.0M | $546.0M | ||
| Q1 24 | $835.0M | $570.3M |
总资产MEIOFIX
| Q4 25 | $1.3B | $850.6M | ||
| Q3 25 | $1.3B | $832.6M | ||
| Q2 25 | $1.3B | $837.2M | ||
| Q1 25 | $1.3B | $823.1M | ||
| Q4 24 | $1.4B | $893.3M | ||
| Q3 24 | $1.4B | $867.9M | ||
| Q2 24 | $1.4B | $882.0M | ||
| Q1 24 | $1.5B | $906.0M |
负债/权益比MEIOFIX
| Q4 25 | 0.49× | — | ||
| Q3 25 | 0.47× | 0.36× | ||
| Q2 25 | 0.46× | 0.34× | ||
| Q1 25 | 0.47× | 0.34× | ||
| Q4 24 | 0.46× | 0.31× | ||
| Q3 24 | 0.40× | 0.23× | ||
| Q2 24 | 0.43× | 0.22× | ||
| Q1 24 | 0.40× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-7.4M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-11.6M | $16.8M |
| 自由现金流率自由现金流/营收 | -4.7% | 7.6% |
| 资本支出强度资本支出/营收 | 1.7% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $52.3M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流MEIOFIX
| Q4 25 | $-7.4M | $27.7M | ||
| Q3 25 | $25.1M | $12.4M | ||
| Q2 25 | $35.4M | $11.6M | ||
| Q1 25 | $28.1M | $-18.4M | ||
| Q4 24 | $-48.0M | $23.7M | ||
| Q3 24 | $10.9M | $11.7M | ||
| Q2 24 | $24.9M | $9.0M | ||
| Q1 24 | $28.8M | $-18.6M |
自由现金流MEIOFIX
| Q4 25 | $-11.6M | $16.8M | ||
| Q3 25 | $18.0M | $2.5M | ||
| Q2 25 | $26.3M | $4.5M | ||
| Q1 25 | $19.6M | $-25.1M | ||
| Q4 24 | $-58.4M | $15.2M | ||
| Q3 24 | $-2.7M | $6.3M | ||
| Q2 24 | $15.8M | $-360.0K | ||
| Q1 24 | $12.2M | $-29.1M |
自由现金流率MEIOFIX
| Q4 25 | -4.7% | 7.6% | ||
| Q3 25 | 7.5% | 1.2% | ||
| Q2 25 | 10.2% | 2.2% | ||
| Q1 25 | 8.2% | -13.0% | ||
| Q4 24 | -20.0% | 7.0% | ||
| Q3 24 | -1.0% | 3.2% | ||
| Q2 24 | 5.7% | -0.2% | ||
| Q1 24 | 4.7% | -15.4% |
资本支出强度MEIOFIX
| Q4 25 | 1.7% | 4.9% | ||
| Q3 25 | 3.0% | 4.8% | ||
| Q2 25 | 3.5% | 3.5% | ||
| Q1 25 | 3.5% | 3.5% | ||
| Q4 24 | 3.6% | 4.0% | ||
| Q3 24 | 5.3% | 2.7% | ||
| Q2 24 | 3.3% | 4.7% | ||
| Q1 24 | 6.4% | 5.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MEI
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
